» Articles » PMID: 27782894

Etiologies, Outcomes, and Prognostic Factors of Pediatric Acute Liver Failure: A Single Center's Experience in Turkey

Overview
Publisher Aves
Specialty Gastroenterology
Date 2016 Oct 27
PMID 27782894
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Our aim was to determine the etiologies, outcomes, and prognostic indicators in children with acute liver failure.

Materials And Methods: Ninety-one patients who were followed for pediatric acute liver failure (PALF) over a 15-year period were included. Patients who survived with supportive therapy were designated as Group 1, while those who died or underwent liver transplantation were designated as Group 2.

Results: There were 37 (40.6%) patients in Group 1 (spontaneous recovery) and 54 (59.4%) patients in Group 2. Thirty-two patients (35.2%) underwent liver transplantation. Infectious and indeterminate causes were the most common etiologies (33% each). Among the infectious causes, hepatitis A (76%) was the most frequent. Hepatic encephalopathy grade 3-4 on admission and during follow-up and high Pediatric Risk of Mortality (PRISM) and Pediatric End-Stage Liver Disease (PELD) scores within the first 24 h were related with a poor prognosis. Group 2 had a more prolonged prothrombin time, higher international normalized ratio, more prolonged activated partial thromboplastin time (aPTT), and higher levels of total and direct bilirubin, ammonia, and lactate (for all, p<0.01).

Conclusion: Infectious and indeterminate cases constituted the most common etiology of PALF, and the etiology was related to the prognosis in our series. Although high PELD and PRISM scores were related to poor prognoses, no sharp thresholds for individual laboratory tests could be elucidated. Liver transplantation was the only curative treatment for patients with poor prognoses and resulted in high survival rates (1-, 5-, and 10-year survival rates of 81.3%, 81.3%, and 75%, respectively) in our study.

Citing Articles

Pediatric acute liver failure: Current perspective in etiology and management.

Samanta A, Poddar U Indian J Gastroenterol. 2024; 43(2):349-360.

PMID: 38466551 DOI: 10.1007/s12664-024-01520-6.


Pediatric acute liver failure: An experience of a pediatric intensive care unit from resource limited settings.

Amatya P, Kapalavai S, Deep A, Sankaranarayanan S, Krupanandan R, Sadasivam K Front Pediatr. 2022; 10:956699.

PMID: 36120651 PMC: 9478462. DOI: 10.3389/fped.2022.956699.


Prognostic factors and scoring systems associated with outcome in pediatric acute liver failure.

Walabh P, Meyer A, De Maayer T, Moshesh P, Hassan I, Walabh P BMC Pediatr. 2022; 22(1):516.

PMID: 36045327 PMC: 9429365. DOI: 10.1186/s12887-022-03574-x.


Prevalence, severity, duration and resolution of cholestasis after acute liver failure.

Warming S, Michel C, Serpa Neto A, Kishore K, Marhoon N, Holmes N BMJ Open Gastroenterol. 2022; 9(1).

PMID: 35473828 PMC: 9045116. DOI: 10.1136/bmjgast-2021-000801.


Development of a prognostic model for pediatric acute liver failure in a Brazilian center.

Junior J, Tannuri A, Tannuri U, Delgado A, Brunow de Carvalho W J Pediatr (Rio J). 2022; 98(6):607-613.

PMID: 35405144 PMC: 9617273. DOI: 10.1016/j.jped.2022.03.002.